Business

Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

Provides Update on the Company’s Innovation Roadmap & New Development Partnerships Highlights new Distribution Agreement with Avantor in the U.S. and Canada

articleQuantum-si IncorporatedNovember 21, 20245/company/quantumsi-inc/news/quantum-si-highlights-major-technical-advances-next-generation-platform-architecture-and-new-proteomic-applications-at-investor-and-analyst-event
Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

About this update from Quantum-si Incorporated

[{"type":"text","content":"\nProvides Update on the Company’s Innovation Roadmap & New Development Partnerships\n\n\nHighlights new Distribution Agreement with Avantor in the U.S. and Canada\n\n\n BRANFORD, Conn.--(BUSINESS WIRE)--\nQuantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024.\n\n\nQuantum-Si’s Management team announced Platinum™ Pro, the Company’s evolution of Platinum, as well as Proteus™, the Company’s new cutting-edge proteomics platform of the future, that is now under development.\n\n\n“We are very excited to have this opportunity to unveil the rapid innovation that we have achieved at Quantum-Si over the last 15 months since our R&D realignment process last August,” said Jeff Hawkins, President and Chief Executive Officer of Quantum-Si. “First, the launch of Platinum Pro will provide meaningful enhancements over our current Platinum platform in relation to workflow, applications and onboard software analysis.”\n\n\nHawkins continued, “Second and most important, we believe the development and launch of our Proteus platform is set to redefine proteomics with unprecedented output per sample, application flexibility and automation. We believe Proteus is the foundational platform to enable billions of sequencing reads and eventually de novo sequencing of the proteome. Finally, with this innovation path, we also believe Proteus and future related innovations will open broad new markets for diverse applications in protein analysis, driving increased revenue growth that will create significant value for our shareholders. With these technology advancements and partnerships in place, we believe we will be able to further extend our leadership position in next-generation protein sequencing while also extending into other areas of proteomics more generally.”\n\n\nPlatinum Pro: Exciting Progress of Enhanced Protein Sequencing\nThe Company announced a next-generation Platinum system, the Platinum Pro, which is scheduled to launch in the first half of 2025. Platinum Pro will provide a streamlined workflow, reducing hands-on time, and faster processing time. Platinum Pro will enable data analysis to be performed locally or using the cloud and will also offer a ‘Pro Mode’, which allo...

More updates from Quantum-si Incorporated